Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Azitra Inc.
DescriptionRecombinant version of Staphylococcus epidermidis that expresses filaggrin (FLG)
Molecular Target Filaggrin (FLG)
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPreclinical
Standard Indication Dermatology (unspecified)
Indication DetailsTreat skin disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today